Clinical Trial Update: Dimethyl Fumarate Treatment of Primary Progressive Multiple Sclerosis [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for dimethyl fumarate in primary progressive multiple sclerosis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Progressive Multiple Sclerosis

Drugs mentioned

• Dimethyl fumarate (Dimethyl fumarate)

Snippet

Sponsor: Rigshospitalet, Denmark | Conditions: Primary Progressive Multiple Sclerosis | Phase 2 | Status: COMPLETED